Novelix Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Novelix Pharmaceuticals has clarified that it is exempt from submitting the annual Secretarial Compliance Report due to its paid-up equity share capital being under ₹10 crore and net worth below ₹25 crore. This exemption arises from specific provisions applicable to smaller listed companies like those on the SME Exchange. The company continues to comply with all other applicable corporate governance norms. This disclosure reassures shareholders about adherence to regulatory requirements while reflecting Novelix’s current scale and status in the market.